Analyst Ratings for Pfizer (PFE)
PFE Rating Summary
PFE Price Target Summary
- Highest: $33.00 (Jefferies)
- Lowest: $22.00 (Barclays)
- Average: $28.25
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$28.25 (-2.5%)
Avg. $ Target:
$28.25 (-2.5%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/7/2013 | Credit Suisse | New Coverage | Neutral (N/A) |
29.00 (N/A) |
27.32 | 28.96 | 6% | Details |
| 11/30/2012 | Citi | New Coverage | Buy (N/A) |
29.00 (N/A) |
24.85 | 28.96 | 16.54% | Details |
| 11/27/2012 | MKM Partners » Updated 1/30/2013 |
Downgrade | Neutral (Buy) |
28.00 (25.00) |
24.49 | 28.96 | 18.25% | Details |
| 9/28/2012 | BMO Capital | New Coverage | Outperform (N/A) |
30.00 (N/A) |
24.96 | 28.96 | 16.03% | Details |
| 4/10/2012 | ISI Group » Updated 4/25/2013 |
New Coverage | Buy (N/A) |
29.00 (N/A) |
22.05 | 28.96 | 31.34% | Details |
| 11/14/2011 | Leerink Swann » Updated 4/10/2013 |
Downgrade | Market Perform (N/A) |
N/A (N/A) |
19.99 | 28.96 | 44.87% | Details |
| 11/1/2011 | Standpoint Research | Downgrade | Hold (N/A) |
N/A (N/A) |
19.67 | 28.96 | 47.23% | Details |
| 9/14/2011 | Barclays » Updated 8/1/2012 |
Downgrade | Equalweight (N/A) |
22.00 (N/A) |
18.33 | 28.96 | 57.99% | Details |
| 8/9/2011 | Goldman Sachs » Updated 5/2/2012 |
Upgrade | Conviction Buy (N/A) |
26.00 (N/A) |
17.49 | 28.96 | 65.58% | Details |
| 1/19/2011 | Wells Fargo | New Coverage | Outperform (N/A) |
N/A (N/A) |
18.38 | 28.96 | 57.56% | Details |
| 11/30/2010 | Credit Agricole | New Coverage | Buy (N/A) |
N/A (N/A) |
16.49 | 28.96 | 75.62% | Details |
| 11/1/2010 | Bernstein | Upgrade | Outperform (N/A) |
N/A (N/A) |
17.42 | 28.96 | 66.25% | Details |
| 10/20/2010 | Cowen | Upgrade | Outperform (N/A) |
N/A (N/A) |
17.39 | 28.96 | 66.53% | Details |
| 5/21/2010 | Jefferies » Updated 4/10/2013 |
New Coverage | Hold (N/A) |
33.00 (31.00) |
15.06 | 28.96 | 92.3% | Details |
| 4/8/2010 | Hapoalim Securities | New Coverage | Hold (N/A) |
N/A (N/A) |
16.71 | 28.96 | 73.31% | Details |
